OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MicroRNAs in Epithelial–Mesenchymal Transition Process of Cancer: Potential Targets for Chemotherapy
Fu Peng, Huali Fan, Li Sui, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7526-7526
Open Access | Times Cited: 14
Fu Peng, Huali Fan, Li Sui, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7526-7526
Open Access | Times Cited: 14
Showing 14 citing articles:
SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma
Weiqiang You, Jia Ke, Yufeng Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Weiqiang You, Jia Ke, Yufeng Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Maackiain Modulates miR-374a/GADD45A Axis to Inhibit Triple-Negative Breast Cancer Initiation and Progression
Fu Peng, Li Wang, Liang Xiong, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24
Fu Peng, Li Wang, Liang Xiong, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24
MiR-182 Is Upregulated in Prostate Cancer and Contributes to Tumor Progression by Targeting MITF
M. Stafford, Declan J. McKenna
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1824-1824
Open Access | Times Cited: 14
M. Stafford, Declan J. McKenna
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1824-1824
Open Access | Times Cited: 14
New Advances in Targeted Therapy of HER2-Negative Breast Cancer
Junsha An, Cheng Peng, Xiaofang Xie, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Junsha An, Cheng Peng, Xiaofang Xie, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology
Jianbo Zhou, Li Wang, Cheng Peng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 16
Jianbo Zhou, Li Wang, Cheng Peng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 16
MicroRNAs, Key Regulators in Glioma Progression as Potential Therapeutic Targets for Chinese Medicine
Huali Fan, Xiaofang Xie, Xi Kuang, et al.
The American Journal of Chinese Medicine (2022) Vol. 50, Iss. 07, pp. 1799-1825
Closed Access | Times Cited: 10
Huali Fan, Xiaofang Xie, Xi Kuang, et al.
The American Journal of Chinese Medicine (2022) Vol. 50, Iss. 07, pp. 1799-1825
Closed Access | Times Cited: 10
Dual Roles of microRNA-122 in Hepatocellular Carcinoma and Breast Cancer Progression and Metastasis: A Comprehensive Review
Essam Al Ageeli
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 11975-11992
Open Access | Times Cited: 1
Essam Al Ageeli
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 11, pp. 11975-11992
Open Access | Times Cited: 1
Potential Anti-Metastatic Role of the Novel miR-CT3 in Tumor Angiogenesis and Osteosarcoma Invasion
Lavinia Raimondi, Alessia Gallo, Nicola Cuscino, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 705-705
Open Access | Times Cited: 8
Lavinia Raimondi, Alessia Gallo, Nicola Cuscino, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 705-705
Open Access | Times Cited: 8
Transcriptomic profiles‐based approach to decode the role of miR ‐122 in triple negative breast cancer
Mauricio Flores‐Fortis, Isidro X. Perez Añorve, Oscar Del Moral Hernández, et al.
Genes Chromosomes and Cancer (2023) Vol. 62, Iss. 7, pp. 392-404
Closed Access | Times Cited: 4
Mauricio Flores‐Fortis, Isidro X. Perez Añorve, Oscar Del Moral Hernández, et al.
Genes Chromosomes and Cancer (2023) Vol. 62, Iss. 7, pp. 392-404
Closed Access | Times Cited: 4
Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review)
Li Sui, Xiaofang Xie, Peng Fu, et al.
International Journal of Oncology (2022) Vol. 61, Iss. 3
Open Access | Times Cited: 6
Li Sui, Xiaofang Xie, Peng Fu, et al.
International Journal of Oncology (2022) Vol. 61, Iss. 3
Open Access | Times Cited: 6
MicroRNA-143 acts as a tumor suppressor through Musashi-2/DLL1/Notch1 and Musashi-2/Snail1/MMPs axes in acute myeloid leukemia
Fanfan Li, Yixiang Han, Rongrong Chen, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Fanfan Li, Yixiang Han, Rongrong Chen, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 2
MiRNA-148a inhibits cell growth and drug resistance by regulating WNT10a expression in renal cell carcinoma
Yongsheng Chen, Wenhua Liu, Dechao Li, et al.
Translational Andrology and Urology (2022) Vol. 11, Iss. 7, pp. 996-1006
Open Access | Times Cited: 4
Yongsheng Chen, Wenhua Liu, Dechao Li, et al.
Translational Andrology and Urology (2022) Vol. 11, Iss. 7, pp. 996-1006
Open Access | Times Cited: 4
Serum Exosomal MiR-874 as a Potential Biomarker for Nonsmall Cell Lung Cancer Diagnosis and Prognosis
Amal F. Gharib, Saad S. Al‐Shehri, Abdulraheem Ali Almalki, et al.
Indian Journal of Medical and Paediatric Oncology (2024)
Open Access
Amal F. Gharib, Saad S. Al‐Shehri, Abdulraheem Ali Almalki, et al.
Indian Journal of Medical and Paediatric Oncology (2024)
Open Access
Dysregulated expression of miR‑367 in disease development and its prospects as a therapeutic target and diagnostic biomarker (Review)
Shaleniprieya Muniandy, Ling Ling Few, Boon Yin Khoo, et al.
Biomedical Reports (2023) Vol. 19, Iss. 6
Open Access
Shaleniprieya Muniandy, Ling Ling Few, Boon Yin Khoo, et al.
Biomedical Reports (2023) Vol. 19, Iss. 6
Open Access
